1. Home
  2. HUMA vs KINS Comparison

HUMA vs KINS Comparison

Compare HUMA & KINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.68

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

KINS

Kingstone Companies Inc.

HOLD

Current Price

$14.21

Market Cap

205.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUMA
KINS
Founded
2004
1886
Country
United States
United States
Employees
220
113
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
205.7M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
HUMA
KINS
Price
$0.68
$14.21
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$9.29
N/A
AVG Volume (30 Days)
8.0M
88.5K
Earning Date
03-27-2026
03-05-2026
Dividend Yield
N/A
1.36%
EPS Growth
N/A
94.59
EPS
N/A
2.88
Revenue
N/A
$214,867,301.00
Revenue This Year
N/A
$10.53
Revenue Next Year
$731.05
$15.00
P/E Ratio
N/A
$5.09
Revenue Growth
N/A
38.50
52 Week Low
$0.70
$13.08
52 Week High
$2.93
$22.20

Technical Indicators

Market Signals
Indicator
HUMA
KINS
Relative Strength Index (RSI) 31.26 33.72
Support Level N/A $13.22
Resistance Level $1.30 $15.58
Average True Range (ATR) 0.10 0.50
MACD -0.04 -0.09
Stochastic Oscillator 2.03 8.91

Price Performance

Historical Comparison
HUMA
KINS

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About KINS Kingstone Companies Inc.

Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.

Share on Social Networks: